Alyeska Investment Group, L.P. Akero Therapeutics, Inc. Transaction History
Alyeska Investment Group, L.P.
- $25 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
210Shares Held
74.3MCall Options Held
321KPut Options Held
558K-
Wellington Management Group LLP Boston, MA7.38MShares$330 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY6.86MShares$307 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$270 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$250 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$234 Million5.21% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.08B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...